AMGN's consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock for now.

Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

MAGA may appeal to politically conservative investors looking to align their portfolios with companies that actively support Republican candidates and causes. But you should be careful not to assume ...

This raises an important question: Are these moves into overbought conditions a signal of potential exhaustion, suggesting ...

Amgen (AMGN) and Kyowa Kirin (KYKOF) announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing therapy targeting ...

Shares of NASDAQ:AMGN opened at $324.86 on Wednesday. The company’s fifty day moving average price is $286.14 and its 200 day moving average price is $299.89. Amgen has a 12 month low of $253.30 ...

Novo Nordisk has a little bit of a positive tone to it in pre-market trading on Friday, as we continue to dance around the 50-day EMA, but you can see this has been a brutal sell-off over the last ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other undervalued stocks. On March 5th, BBC reported that the US stock market had fallen after the ...

In a report released on March 2, David Risinger from Leerink Partners maintained a Hold rating on Amgen (AMGN – Research Report). The company’s shares closed yesterday at $312.19. See what ...